Dr. Boeri earned his degree in Industrial Biotechnology in 2006, with a thesis developed at the Institute of Pharmacological Research “Mario Negri” of Milan (Italy). He then attended the bioinformatics laboratories of Prof. Duccio Cavalieri of the University of Florence (Italy) and Prof. Eitan Rubin of the Ben Gurion University in Be’er Sheva (Israel) as a visiting student for training.
In 2007 Dr. Boeri has joined the laboratory of Tumor Genomics at the Fondazione IRCCS Instituto Nazionale dei Tumori (INT) of Milan, working on a project focused on the characterization of the YAP1 oncogene and its role in paediatric tumours. In 2010 he started his Ph.D. program at the INT, affiliated to the Open University of London, to investigate the role of microRNAs in early lung cancer. During the 4 years of Ph.D, he has originally developed a novel bioinformatics tool based on the evaluation of microRNA reciprocal ratios in plasma, generating an algorithm that allowed to efficiently discriminate lung cancer screening patients from controls.
Dr. Boeri is now completing his post-doc period as responsible of the molecular analysis of the Biomild lung cancer screening trial headed by Dr. Ugo Pastorino, Director of the Division of Thoracic Surgery at the INT. Dr. Boeri is a member of the Società Italiana di Cancerologia (SIC), the European Association of Cancer Research (EACR), the American Association of Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC). He attended several international meetings as invited and selected speaker and he received awards and honors such as the FIRC/AIRC three-year fellowship, the Scholar-in-Training Award for AACR Annual Meeting, the Young Researchers Award of the INT and post-doc fellowships of the Veronesi Foundation and the Pezcoller Foundation.